A federal magistrate judge recommended certifying a nationwide class action in a federal court in Miami, which is scheduled for trial Oct. 26 and alleges a pharmaceutical company sold a “worthless” product that was designed to help with memory loss.

On Thursday, U.S. Magistrate Judge Jonathan Goodman of the the Southern District of Florida recommended certifying a class of consumers who purchased Prevagen over the last four years. The Moskowitz Law Firm and Searcy Denney will represent the plaintiffs at trial.